This speed freak of nature’s drug use was X-treme.
A British guy is said to have established a new drugs world record after consuming 40,000 ecstasy tablets over the course of nearly a decade and surviving to tell the story. The extreme drug binge was first documented in 2006, but is currently exploding online after MDMA received “rave” reviews from medical experts as a potential PTSD treatment following a “phase 3, double-blind, randomized, placebo-controlled trial” conducted by doctors from the University of California San Francisco and New York University.
Dr. Christos Kouimtsidis, a psychiatrist located in the United Kingdom, noted in the mind-blowing report published in the medical journal “Psychosomatics”: “To our knowledge, this is the highest amount of ecstasy ever consumed in a lifetime.”
The case study was noteworthy since nothing was known at the time about the association between the severity and duration of these disorders and the lifetime quantity of ecstasy pills used.
According to the study, Mr. A, a 37-year-old raver, used MDMA frequently between the ages of 21 and 30 after becoming deeply involved in the “club scene.” According to DEA.org, MDMA, often known as Molly, “acts as both a stimulant and psychedelic, creating an energetic impact, distortions in time and perception, and greater pleasure of tactile encounters,” making it a popular designer drug in nightclubs.
The native of Surrey began taking five tablets every weekend before increasing his dosage to 3.5 pills every day during the following years. He subsequently increased this quantity to a “XXX-L” dosage of 25 pills per day, which he would take for the balance of his independent medication studies.
Mr. A’s doctor, Kouimtsidis, told the Daily Mail that “typical use is not daily and not the number of pills he was taking.” “It was tremendous; his use was really, extremely excessive.”
The psychedelic explorer consumed a total of 40,000 ecstasy tablets over the course of nine years, surpassing the previous record of 20,000 tablets established in a 1998 research.
According to the research, Mr. A only stopped his X-treme routine after “collapsing” at three distinct parties. However, Dr. Koumtsidis said that the reformed partygoer had so much ecstasy in his system that he stayed euphoric “for a few months” after quitting.
Mr. A also suffered from a multitude of serious long-term side effects, including episodes of “tunnel vision,” severe panic attacks, melancholy, muscular stiffness, hallucinations, and even paranoid ideation. According to a state medical assessment, other symptoms included poor focus, issues with short-term memory, and confusion to time.
In October, a psychedelic US research indicated that a chemical similar to LSD might possibly be used to treat depression in people without the psychedelic side effects.
The Getty Images/iStockphoto collection
It appears incredible that Mr. A survived such a widespread attack. However, MDMA overdoses are extremely uncommon and typically result from dehydration or contamination with another illegal substance. According to toxicology specialists, an overdose of any drug, whether illegal or not, can be lethal.
Mr. A was administered 10 milligrams of olanzapine and admitted to a brain-injury facility following his ecstasy overdose, where his memory abilities improved due to the application of compensatory methods, according to the study.
Following breakthrough trials confirming its usefulness as a PTSD therapy, MDMA may become available in U.S. hospitals by 2024, according to recent reports. The 2021 clinical study including 90 individuals with severe PTSD indicated that 88% achieved remission after using Molly and talk therapy.
This may come as a surprise considering the drug’s reputation for inducing all-night dancing. However, MDMA is believed to function by retraining neurological connections; specifically, molly calms the brain’s fear regions, allowing PTSD patients to discuss their experience with a therapist rather than keeping it locked up, as reported by The Guardian.
A second phase 3 study of MDMA, undertaken by the The Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC), was concluded in the United States this month, but the results have not yet been made public. According to the Daily Mail, these party drug dry runs featured participants with less acute PTSD and more persons of race.
As these new studies were finished ahead of schedule, according to a MAPS PBC representative, a New Drug Application may be submitted to the FDA by mid-2023 and approved in as little as six months. This means that it might be made available to some of the 12 million American adults suffering from PTSD as early as the fall of 2024.
Moreover, this could pave the way for the approval of additional psychedelics to treat a wide range of conditions, from PTSD to anxiety.
In October, a psychedelic US research indicated that a chemical similar to LSD might possibly be used to treat depression in people without the psychedelic side effects.
»I ingested 40,000 ecstasy tablets; physicians stated I was “very, really high” for months.«